Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
EW · against 59 other Healthcare companies of similar size
Ranked #49 of 60 · scores higher than 17% of peers
Bars: peers in each 10-point band of the valuation score9 peers with a valuation score of 40–49, including EW · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | EW | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 57 reported | 1.8% | 3.0% | 16% | 30% | |
| EBITDA yieldHigher is better · 61 reported | 3.9% | 6.2% | 27% | 50% | |
| Free cash flow yieldHigher is better · 44 reported | 2.6% | 4.0% | 28% | 20% | |
| Book yieldHigher is better · 56 reported | 19.3% | 22.2% | 44% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 4.61T JPY (≈$31.3B) | 93 | 76 | |
| 2 | 78.1B USD | 89 | 60 | |
| 3 | 108.6B USD | 88 | 66 | |
| 4 | 97.5B USD | 87 | 67 | |
| 5 | 6.17T JPY (≈$42.0B) | 86 | 70 | |
| 46 | 327.3B CNY (≈$45.8B) | 49 | 75 | |
| 46 | 52.9B USD | 49 | 57 | |
| 48 | 28.6B USD | 48 | 60 | |
| 49 | 43.30T KRW (≈$31.2B) | 47 | 68 | |
| 49 | 54.9B USD | 47 | 59 | |
| 51 | 40.2B USD | 46 | 73 | |
| 51 | 49.1B USD | 46 | 69 | |
| 53 | 66.3B USD | 44 | 30 | |
| 54 | 56.7B USD | 42 | 79 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score